Rüdiger Hehlmann
Rüdiger Hehlmann
New insights have emerged from maturing long-term academic and commercial clinical trials regarding optimum management of chronic myeloid leukemia (CML). Velocity of response has unexpectedly proved less important than hitherto thought, doe...
Rapid Generation of Leukemogenic Chromosomal Translocations in Vivo Using CRISPR/Cas9 [0.03%]
利用CRISPR/Cas9技术在活体中快速生成 leukemogenic染色体重排
Yun Huang,Blerim Marovca,Susanne Dettwiler et al.
Yun Huang et al.
Symeon Metallidis,Georgia Gioula,Maria Papaioannou et al.
Symeon Metallidis et al.
Case Reports
HemaSphere. 2020 Sep 30;4(5):e419. DOI:10.1097/HS9.0000000000000419 2020
SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience [0.03%]
早期意大利经验中的骨髓增生异常综合症的SARS-CoV-2感染情况一览
Sandra Mossuto,Enrico Attardi,Francesco Alesiani et al.
Sandra Mossuto et al.
A Phase 2 Study of Nivolumab Using a Fixed Dose of 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkin Lymphoma [0.03%]
使用固定剂量40毫克（Nivo40）的尼沃单抗治疗复发/难治性霍奇金淋巴瘤患者的2期研究
Kirill V Lepik,Liudmila V Fedorova,Elena V Kondakova et al.
Kirill V Lepik et al.
The introduction of nivolumab has changed the landscape of relapsed/refractory classical Hodgkin lymphoma (r/r cHL) treatment. Despite its clinical importance, this therapy may remain inaccessible for a significant number of patients worldw...
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO) [0.03%]
慢性淋巴细胞白血病的诊断与治疗：法国CLL研究小组(FILO)建议
Anne Quinquenel,Thérèse Aurran-Schleinitz,Aline Clavert et al.
Anne Quinquenel et al.
As a result of significant recent developments, the management of patients with chronic lymphocytic leukemia (CLL) is changing, and new therapeutic options will continue to emerge in the near future. The recommendations of the French Innova...
SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma [0.03%]
经典霍奇金淋巴瘤患者使用托西珠单抗治疗新型冠状病毒肺炎一例报告
Chiara Rusconi,Giulio Cassanello,Anna Guidetti et al.
Chiara Rusconi et al.
Case Reports
HemaSphere. 2020 Sep 1;4(5):e472. DOI:10.1097/HS9.0000000000000472 2020
Polycythemia Vera Evolution to Chronic Myelomocytic Leukemia: The Prognostic Value of Next Generation Sequencing [0.03%]
真性红细胞增多症演变为慢性粒单核细胞白血病：新一代测序的预后价值
Maria Huguet,Lurdes Zamora,Isabel Granada et al.
Maria Huguet et al.
Case Reports
HemaSphere. 2020 Sep 1;4(5):e466. DOI:10.1097/HS9.0000000000000466 2020
Emmanuel Bachy,Alessandro Broccoli,Claire Dearden et al.
Emmanuel Bachy et al.
Peripheral T-cell lymphomas are a heterogeneous group of rare diseases with an aggressive behavior and dismal prognosis. Their classification is complex and still evolving, and several biomolecular markers now help refine the prognosis of s...
Control of Systemic Iron Homeostasis by the 3' Iron-Responsive Element of Divalent Metal Transporter 1 in Mice [0.03%]
小鼠二价金属转运蛋白1的3'铁反应元件对系统性铁稳态的控制
Elisabeth Tybl,Hiromi Gunshin,Sanjay Gupta et al.
Elisabeth Tybl et al.
Supplemental Digital Content is available in the text. Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Europea...